脑胶质瘤显微外科术中实时超声的应用  

Intraoperative real-time ultrasound in glioma microsurgical operation

作　　者：路长宇[1] 贾文清 

机构地区：[1]北京市门头沟区医院神经外科,102300 [2]北京天坛医院神外三病区,100050

出　　处：《中国实用医刊》2017年第10期51-53,共3页Chinese Journal of Practical Medicine

摘　　要：目的 探讨脑胶质瘤显微手术中实时超声干预的作用.方法 选择脑胶质瘤患者66例,按照随机数字表法分为观察组（35例）和对照组（31例）.观察组采用显微外科手术切除病灶,术中辅以实施超声技术监测,指导肿瘤切除;对照组单纯实施显微外科手术.对比两组患者的肿瘤全切率、术中出血量、手术时间及并发症发生率.结果 观察组全切率为85.71%,对照组为61.29%,差异有统计学意义（P〈0.05）;观察组手术时间为（230.11±66.57）min,对照组为（293.16±98.12）min,差异有统计学意义（P〈0.05）;观察组术中出血量为（501.06±98.13）ml,对照组为（558.61±101.99）ml,差异有统计学意义（P〈0.05）;观察组并发症发生率为34.29%,对照组为61.29%,差异有统计学意义（P〈0.05）.结论 脑胶质瘤显微手术结合术中超声实时监测可有效提高肿瘤的全切率,减少出血量、缩短手术时间并降低并发症的发生.Objective To evaluate the clinical value of intraoperative real-time ultrasound in glioma microsurgical operation.Methods Sixty-six patients with glioma were randomly divided into the observation group（35 cases） and the control group（31 cases）.All the patients received the treatment of microneurosurgical operation.But intraoperative real-time ultrasound technology was applied in the observation group to guide tumor resection.The total resection rate of tumor,amount of bleeding,operative time and the incidence of complication were compared between the two groups.Results The total resection rate of tumor in the observation group was 85.71% and it was 61.29% in the control group,there was significant difference between the two groups（P〈0.05）.The operative time of the observation group was （230.11±66.57） min and （293.16±98.12） min in the control group,there was significant difference between the two groups（P〈0.05）.The incidence rate of complication in the observation group was 34.29%,and it was 61.29% in the control group,there was significant difference between the two groups（P〈0.05）.Conclusions Intraoperative real-time ultrasound in glioma microsurgical operation can improve the total resection rate of tumor,shorten the operation time,reduce the loss of blood during operation and the incidence of complication.

关 键 词：脑胶质瘤 显微手术 实时超声 全切率 

分 类 号：R445.1[医药卫生—影像医学与核医学] R739.41[医药卫生—诊断学]